Author Topic: F.D.A. Revises Its Letter for Nonapproval of Drugs  (Read 639 times)

0 Members and 1 Guest are viewing this topic.

Offline feedbot

  • Επίλεκτο μέλος
  • *****
  • Posts: 6686
  • Κάπνισμα: Δεν κάπνισα ποτέ
F.D.A. Revises Its Letter for Nonapproval of Drugs
« on: 10 Jul, 2008, 11:00:15 »
F.D.A. Revises Its Letter for Nonapproval of Drugs
     


Drug makers whose products are not ready for approval in the U.S. will soon get the word from regulators in a new format intended partly to avoid scaring investors.<br/><br/><span class="advertisement">    <a href="http://www.pheedo.com/click.phdo?x=07ef2180cee44d9abb689f9f7fe272d1&u=http://www.nytimes.com/2008/07/10/business/10drug.html"><img src="http://www.pheedo.com/img.phdo?x=07ef2180cee44d9abb689f9f7fe272d1&u=http://www.nytimes.com/2008/07/10/business/10drug.html" border="0"/></a></span>

     

http://www.nytimes.com/2008/07/10/business/10drug.html?partner=rssnyt&emc=rss